Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
Status:
Terminated
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Current therapies for adult recurrent/progressive low grade astrocytoma provide
limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest
that it may prove beneficial in the treatment of adult recurrent/progressive low grade
astrocytoma.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on adults with a recurrent/progressive low grade astrocytoma.